Search

Women with Stage III ovarian cancer when treated with a combination of intravenous (IV) and intra-abdominal chemotherapy, following the successful surgical removal of tumors, survived almost a year longer than those who received IV chemotherapy alone.

… Wednesday, January 4, 2006 According to a study published in the January 5 issue of the New England Journal of Medicine , women with Stage III ovarian cancer given a combination of intravenous (IV) and intra-abdominal chemotherapy, following the successful surgical removal of tumors, experienced a median

An MSK expert gives advice on how to talk to family and friends about a cancer diagnosis linked to HPV, which some people find particularly challenging.

… Tuesday, May 3, 2022 Talking about a cancer diagnosis can be tough. Talking with friends, family, and others about a cancer diagnosis linked to HPV can be particularly challenging for many people. Memorial Sloan Kettering Cancer Center (MSK) clinical social worker Victoria Lassen has counseled people

Un experto de MSK ofrece consejos sobre cómo hablar con familiares y amigos sobre un diagnóstico de cáncer relacionado con el VPH, algo que para algunas personas puede resultar especialmente difícil.

… Tuesday, May 3, 2022 Hablar sobre un diagnóstico de cáncer puede ser difícil. Hablar con amigos, familiares y otras personas sobre un diagnóstico de cáncer relacionado con el VPH puede resultar especialmente difícil para muchas personas. Victoria Lassen , trabajadora social clínica del Memorial Sloan

Paige Arnold, a graduate student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), is one of 13 PhD candidates selected from around the world to receive a Harold M. Weintraub Graduate Student Award for the quality, originality, and significance of their doctoral research.

… Wednesday, March 2, 2022 Paige Arnold , a graduate student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), is one of 13 PhD candidates selected from around the world to receive a Harold M. Weintraub Graduate Student Award for the quality, originality, and significance of

A new drug could be an effective treatment for some people with low-grade glioma.

… Wednesday, August 7, 2024 Brain tumors are among the deadliest and most difficult cancers to treat. But the US Food and Drug Administration (FDA) has now approved a new drug that slows the growth of low-grade diffuse gliomas with a certain gene mutation.  “This represents the first new treatment option

By deciphering the biology of T cells, MSK scientists gave immunotherapy a boost.

… Wednesday, December 28, 2016 Immunologists are fond of car analogies. The T cells that protect us from infections and cancer, they say, have an ignition switch. They also have gas pedals and brakes. How immunologists, like good molecular mechanics, deciphered what makes T cells hum is a story that reaches

Cell replacement therapy seeks to restore function in the body by replacing cells that are lost due to disease or injury with new, healthy cells. One disease for which this type of therapy holds particular promise is the degenerative neurological disorder Parkinson’s disease, which is characterized by symptoms related to movement.

… Tuesday, August 21, 2012 Summary Cell replacement therapy seeks to restore function in the body by replacing cells that are lost due to disease or injury with new, healthy cells. One disease for which this type of therapy holds particular promise is the degenerative neurological disorder Parkinson’s

Studies conducted in mice reveal a potential way to breach the defenses of pancreatic cancer tumors.

… Tuesday, March 31, 2020 Summary In a study published March 31, researchers at the Sloan Kettering Institute report that a two-drug combination makes pancreatic cancer more sensitive to immunotherapy in mouse models. Pancreatic cancer is one of the most challenging cancers to treat. In part, that’s because

Learn how highly focused, intense radiation can stop lung cancer from growing after it has spread to a small number of sites.

… Thursday, December 14, 2023 Non-small cell lung cancer (NSCLC) , the most common form of lung cancer , is often diagnosed at an advanced  stage . About half the time, it has already spread around the body and has reached stage 4. The standard treatment for most patients with metastatic NSCLC is systemic

Obtenga información sobre cómo la radiación intensamente focalizada y de alta dosis puede detener el crecimiento del cáncer pulmonar después de que se ha diseminado a una pequeña cantidad de sitios.

… Thursday, December 14, 2023 El cáncer pulmonar de células no pequeñas (CPCNP) , la forma más común de cáncer pulmonar , suele diagnosticarse en un estadio  avanzado . Aproximadamente la mitad de las veces, ya se ha diseminado por el cuerpo y ha alcanzado el estadio 4. El tratamiento convencional para